FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts Today, the U.S. Food and Drug Administration issued an emergency use...
Semaglutide for Weight Loss? A Good First STEP, With Caveats

Semaglutide for Weight Loss? A Good First STEP, With Caveats

The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named, some say. “In sum, we have a long way to go to control the obesity epidemic…but on the face of it,...
COVID-19 Vaccines in Late-Stage Development

COVID-19 Vaccines in Late-Stage Development

Vaccines in Late-Stage Development The following vaccines are in, or have completed, phase 3 clinical trials in the United States. On December 18, 2020, the US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the mRNA-1273 SARS-CoV-2...

Pin It on Pinterest